MassMutual Private Wealth & Trust’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.95K Hold
269
– – ﹤0.01% 1485
2026
Q2
$8.29K Hold
269
– – ﹤0.01% 1483
2026
Q1
$5.81K Hold
269
– – ﹤0.01% 1612
2025
Q4
$6.41K Hold
269
– – ﹤0.01% 1574
2025
Q3
$3.66K Hold
269
– – ﹤0.01% 1791
2025
Q2
$2.19K Buy
+269
New +$2.3K ﹤0.01% 1924
2025
Q1
– Sell
-7
Closed -$104 – 2462
2024
Q4
$104 Sell
7
-97
-93% -$1.58K ﹤0.01% 2284
2024
Q3
$1.59K Buy
104
+8
+8% +$126 ﹤0.01% 1715
2024
Q2
$1.46K Sell
96
-4
-4% -$65 ﹤0.01% 1731
2024
Q1
$1.89K Hold
100
– – ﹤0.01% 1558
2023
Q4
$1.91K Buy
100
+26
+35% +$416 ﹤0.01% 1513
2023
Q3
$1.33K Hold
74
– – ﹤0.01% 1611
2023
Q2
$1.5K Hold
74
– – ﹤0.01% 1549
2023
Q1
$1.35K Buy
74
+8
+12% +$153 ﹤0.01% 1524
2022
Q4
$1K Buy
+66
New +$1.82K ﹤0.01% 1524

Other funds holding RCUS

MassMutual Private Wealth & Trust's RCUS Position: Q3 2026 in Review

MassMutual Private Wealth & Trust held its Arcus Biosciences (RCUS) position steady in Q3 2026 at 269 shares worth $6.95K. The position accounts for ﹤0.01% of the portfolio, ranked #1485.

MassMutual Private Wealth & Trust first reported a position in RCUS in Q4 2022 and has held it in 15 quarters since. The position peaked at $8.29K in Q2 2026. 244 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.

  • MassMutual Private Wealth & Trust held 269 shares of Arcus Biosciences worth $6.95K as of Q3 2026.
  • MassMutual Private Wealth & Trust left its Arcus Biosciences share count unchanged in Q3 2026.
  • Arcus Biosciences made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #1485 holding.
  • MassMutual Private Wealth & Trust first reported a position in Arcus Biosciences in Q4 2022 and has held it in 15 quarters since.
  • MassMutual Private Wealth & Trust's Arcus Biosciences position peaked at $8.29K in Q2 2026.
  • 244 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.